Evonik's Q3 2025 EBITDA Forecast Down, Insiders Buy Shares
Evonik Industries has revised its expectations for the third quarter of 2025, with EBITDA now forecasted between 420 to 460 million euros, down from previous estimates of around 500 million euros. Meanwhile, members of Evonik's management board, including Claudine Mollenkopf and Thomas Wessel, have been investing in the company's shares, suggesting potential confidence in its operating business.
Claudine Mollenkopf, a member of Evonik's management board, recently invested 95,875 euros in 6,500 Evonik shares. This follows a purchase by Thomas Wessel, Evonik's long-standing personnel director, who bought 2,999 shares in August. These insider transactions come despite Evonik's stock experiencing a steady decline over the past few weeks and months.
The company's recent EBITDA earnings stood at 577 million euros in the previous quarter. However, Evonik has since lowered its third quarter 2025 EBITDA forecast to the current range of 420 to 460 million euros. Market expectations had previously been around 500 million euros. No recent information was found about additional share acquisitions by insiders or the expected end dates of their stock purchases.
Evonik's stock performance and revised EBITDA forecasts may give pause to potential investors. However, insider purchases by Mollenkopf and Wessel could signal confidence in the company's operating business. DER AKTIONÄR recommends waiting for improved operating business prospects and a more favorable chart picture before considering an investment in Evonik.
